Bean Bag Chairs Market Size Worth $4.3 Billion By 2025

The global bean bag chairs market size is anticipated to reach USD 4.3 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.0% over the forecast period. Rising construction activities in developed countries including U.S., Germany, U.K., and France are expected to assist in the growth of this market. In addition, supportive government initiatives such as homes for all will promote growth of the market.

For instance, in 2018, the German government tried to speed up the construction of housing and limit rent rises as it seeks to tackle a drastic shortage of affordable housing. The government plans to build around 1.5 million new houses by 2021. Furthermore, they are planning to invest over 5 billion euros for social housing and expected to build around 100,000 new social flats by 2021.

The indoor segment held a leading share of 78.4% in 2018. Gradually, rooms in modern house are losing their traditional use and becoming spaces with numerous possible functions. Beanbags can cater to that need by being portable and functioning as a seat, side table, footstool or floor cushion. The outdoor segment is anticipated to expand at the fastest CAGR of 5.2% over the forecast period owing to growing popularity of these chairs in offices and restaurants.

The online segment is anticipated to expand at the fastest CAGR of 6.4% over the forecast period. Increasing penetration of smartphone and exposure to digital media, especially in developing countries such as India and China, is expected to assist in sale of these products through the online channel. In addition, online retailers such as Wayfair.com and Brookstone.com are focusing on making this product a main category in modern furniture, thereby boosting the growth of bean bag chairs market.

Europe held a leading share of 37.4% in 2018. The market is driven by rise in the construction of houses in the region. Asia Pacific is projected to witness the fastest growth over the forecast period due to rising popularity of luxury and branded furniture including bean bag chairs, especially in countries like India and China. Moreover, increasing penetration of players such as MUJI and IKEA, coupled with surge in number of retail outlets, is expected to promote growth of the market in upcoming years.

Key players operating in the market include Lovesac; Yogibo LLC; Fatboy; SUMO LOUNGE INTERNATIONAL; AFA Inc.; LUVU BRANDS; CordaRoy’s; Comfy Sacks; Lumaland Inc.; and MUJI.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/bean-bag-chairs-market

Further key findings from the study suggest:

North America is anticipated to witness significant growth from 2019 to 2025 owing to shifting consumer preference from conventional to modern and luxury furniture
The bean bag chairs market in Europe was valued at USD 1.2 billion in 2018
Asia Pacific is anticipated to expand at the highest CAGR of 5.8% from 2019 to 2025 due to rise in product availability
The global market is highly competitive in nature due to presence of key players such as Lovesac and Yogibo LLC.

Animal Genetics Market Size Worth $8.9 Billion By 2026

The global animal genetics market size is expected to reach USD 8.9 billion by 2026, according to a new report by Grand View Research, Inc. exhibiting a CAGR of 4.9%. The market for animal genetics is anticipated to witness rise in demand owing to factors such as increasing consumption of animal proteins and rapid global urbanization. To fulfill the continuously rising demand, the preference for genetics to breed high-quality livestock and secure large production has increased. The demand for animal genetics has increased over the years, owing to rise in various animal diseases, increasing prevalence of zoonotic diseases, and rise in adoption of pets & companion animals.

According to Food and Agriculture Organization (FAO) publication 2017, livestock contributes almost 40% to the global value of agricultural output, and it supports food security and livelihood of more 1.5 billion people worldwide. However, the increasing land requirement for these animals and grazing is a major environmental concern. Public awareness regarding such concerns is a major reason leading to the shift toward white meat and vegan lifestyle, impeding growth of animal genetics. However, increasing support and research by government organizations to improve productivity is aiding growth. For instance; Animal Improvement Program Launched in 2014, by Animal Genomics and Improvement Laboratory (AGIL), which is an agricultural research service organization of USDA. The program aims at improving productivity and efficiency of dairy animals & ruminants.

The market follows the standards set by International Society of Animal Genetics (ISAG) and leading animal research laboratories such as The University of California Davis (U.C. Davis). The ISAG standard panel consists of 18 STR markers, and any company in animal genetics needs to follow the panel and standards set by the authorities. The need for high investments in development of new technology and the duration of product launch are some of the major factors resulting in steady growth. However, increasing population is expected to pose an ongoing challenge due to rise in the need for animal protein, aiding developments in the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/animal-genetics-market

Further key findings from the report suggest:

Porcine segment was the largest revenue-generating segment in 2018, owing to increasing consumption of pig meat in the European countries
The embryo segment accounted for the largest revenue share, based on genetic material, in 2018, owing to the large numbers of embryos produced and sold in countries such as France, Canada, Brazil, and Spain
In the services segment, the genetic diseases testing segment accounted for the largest share in 2018 and is expected to maintain its dominance throughout the forecast period
The North American animal genetics market is the leading region and accounted for the largest revenue share in 2018, mainly due to existence of significant number of research and development activities in the region
The Asia Pacific region is expected to grow at the highest rate during the study period. Growing population coupled with increasing demand for animal protein is a major factor aiding regional growth
Some of the major players are Genus Plc; Envigo Corporation; Topigs Norsvin; CRV Holding B.V; Groupe Grimaud La Corbiere SA; Hendrix Genetics BV; Neogen Corporation; Zoetis, Inc; URUS; and Animal Genetics, Inc.

Predictive Genetic Testing & Consumer/Wellness Genomics Market Worth $8.5 Billion By 2025

The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 8.5 billion by 2025, registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. Factors influencing the market progression include growing awareness about utilization of genetic tests that aid in prediction of gene susceptibility to disease development prior to symptoms. Moreover, rise in sales of these products owing to growing inclination of physicians is driving the market.

Introduction of novel platforms in next-generation sequencing technology aids in enhancing the accuracy of predictive genetic and consumer genomics kits. Market participants are engaged in implementing novel protocols to launch products that require minimal technical assistance and provide optimal customer satisfaction.

Pharmaceutical firms are engaged in several agreement models with genomic vendors for the release of novel therapeutics based on patient’s phenotypic and genotypic information. For instance, in July 2018, GlaxoSmithKline plc purchased 23andMe’s customer data to develop a new drug, thus promoting patient-centered healthcare.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/predictive-genetic-testing-consumer-wellness-genomics-market

Further key findings from the study suggest:

High adoption rate of these products in clinical practice for detection of disease susceptibility resulted in the largest share of this segment in 2018
Growing awareness related to direct to consumer (DTC) genetic tests and entry of new players is attributive to the fastest growth of the consumer genomics segment
Genetic susceptibility tests are of great interest in gynecology and endocrinology-related research and diagnosis, thus allowing it to capture the maximum revenue share. These tests enable the identification of susceptible genes or mutations in adenomyosis, endometriosis, and postmenopausal osteoporosis
Application of predictive genetic and consumer genomics is highest in the detection of breast and ovarian cancer as these tests hold the potential to identify BRCA mutations in patients
Advent of predictive tests for identification of MLH1, MSH2 genes for colorectal cancer diagnosis is expected to fuel market growth in the coming years
Colorectal screening initiatives such as mass screening and population-based screening are expected to boost segment growth
North America dominated the market with the largest revenue share in 2018 owing to the presence of major players and high adoption rate
Asia Pacific is expected to witness substantial growth in the coming years owing to increasing adoption of these products in developing economies
Manufacturers contributing significantly to market growth include Pathway Genomics; ARUP Laboratories; BGI; Illumina, Inc.; 23andMe, Inc.; Color Genomics Inc.; and Myriad Genetics, Inc. Established as well as emerging companies are involved in adopting strategic moves for the launch of novel products.

Patient Temperature Management Market Worth $5.0 Billion By 2026

The global patient temperature management market size is anticipated to reach a value of USD 5.0 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. A rising number of surgeries is anticipated to accelerate the demand for temperature management devices. For instance, open heart surgeries require lowering down the body heat of patients through blood cooling, which helps reduce the risk of the post and perioperative surgical complications.

With the growing prevalence of cardiac arrest and other chronic cardiac diseases, there is a rising number of surgeries being undertaken. This growth is anticipated to drive the need for patient temperature management, to avoid the adverse effects on the brain. Patient warming systems are also used for cancer patients as adjuncts with chemotherapy and radiation therapy for more effective results. Moreover, in neonatal care, newborns are likely to experience temperature fluctuations and hence, they are kept in incubators to maintain their normal body temperature. The aforementioned factors are driving demand for temperature monitoring devices.

With the rising demand for conventional warming and cooling devices, there is a growing need for modern temperature management systems. The introduction of a wide range of surface warming and cooling systems by major companies is expected to positively impact the market growth during the forecast period. The blood and fluid temperature management devices have also evolved over the years and are applied through a catheter by circulating warm or cool saline in the patients’ body.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/patient-temperature-management-market

Further key findings from the study suggest:

Patient warming systems led the market in 2018 due to a rise in the number of surgeries, which lower the body temperature of patients due to the use of general anesthesia
Patient cooling systems are anticipated to exhibit a lucrative CAGR over the forecast period due to the introduction of new products like cooling caps and blood and fluid cooling systems
Surgery segment held the largest market share in 2018 due to the increasing number of cardiac and gynecological surgeries across the globe
Operating rooms segment is expected to generate huge revenue due to a large number of surgical procedures being performed and the need for temperature management during these surgeries
In 2018, North America led the patient temperature management market due to rising demand for technologically advanced products in this region
Asia Pacific is expected to showcase lucrative growth over the forecast period, due to increasing sedentary lifestyle resulting in cardiac-related disorders
Some of the major companies operating in the market include Stryker Corporation; ZOLL Medical Corporation; Cincinnati Sub-Zero Products, LLC; Medtronic, Inc.; 3M Company; Bard Medical, Inc.; and The 37Company

General Surgery Devices Market Worth $26.5 Billion By 2026

The global general surgery devices market size is expected to reach USD 26.5 billion by 2026 registering a CAGR of 8.5%, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures being performed coupled with technological advancements is anticipated to drive the market. Moreover, rising awareness and patient affordability for plastic or reconstructive surgeries would propel the number of procedures conducted during the forecast period.

Global health initiatives for the advanced surgical procedure is expected to boost the market. In January 2017, Ethiopia Federal Ministry of Health (FMOH) launched the Health Sector Transformation Plan (HSTP) and Safe Surgery (SaLTS) program that prioritizes safe surgery and makes anesthesia care and emergency surgical services accessible and affordable.

Technological advancements are also contributing to the market growth. Several key companies are investing in R&D for the development of innovative products. For instance, development of medical robots to assist surgeons is a key advancement in the field. Medical robots offer several advantages, such as a 3D view of the operating field, reduced blood loss & transfusions, lower risk of infection, faster recovery time, minimal scarring, and high precision.

Furthermore, growing aging population and cases of road accidents and increased healthcare expenditure in emerging economies are likely to boost the market during the forecast period. According to the WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050 from 900 million in 2015. Geriatric population is more susceptible to a number of diseases, which is likely to increase the need for effective treatments, thereby driving the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market

Further key findings from the study suggest:

Disposable surgical supplies held the largest market share in 2018. Low product cost and regulatory support for the usage of disposable products is expected to fuel the demand for these devices
Asia Pacific is estimated to expand at the highest CAGR over the forecast period due to technological advancements, increasing investments and improving reimbursement scenario along with the growing medical tourism sector in the region
Medical robotics & computer-assisted surgery devices are projected to witness the maximum CAGR of 9.9% from 2019 to 2026 due to increasing R&D investments and availability of technologically advanced products
Some of the key companies in the market are Medtronic plc; Johnson & Johnson Services, Inc.; CONMED Corp.; Becton, Dickinson and Company (BD); B Braun Melsungen AG; Strykers; Boston Scientific Corp.; Erbe Elektromedizin GmbH; and The 3M Company

Lymphoma Treatment Market Size Worth $26.4 Billion By 2026

The global lymphoma treatment market size is expected to reach USD 26.4 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.5%. Rising research activities for development of new treatments and increasing product line extension are likely to expedite growth. Increasing commercialization of novel drugs are further expected to drive the growth.

Availability of wide variety of products is further expected to aid growth. For instance, in January 2019, BeiGene received a breakthrough therapy designation by the U.S. FDA for its product Zanubrutinib for treating mantle cell lymphoma in adults. This drug is currently in late-stage clinical trial and is expected to be launched during the forecast period.

Growing awareness about early diagnosis of lymphoma among healthcare professionals & patients and rising government funding for R&D are some factors expected to propel market growth. For instance, institutes such as National Cancer Institute receives funding from the U.S. Congress to support cancer-related research and associated activities.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/lymphoma-market

Further key findings from the report suggest:

Non-Hodgkin lymphoma held the largest share in 2018 owing to prevalence of non-Hodgkin lymphoma and presence of blockbuster drugs.
Hodgkin lymphoma is expected to be the fastest growing segment due to presence of strong product pipeline and increase in the number of label extension for existing drugs.
Based on drug, Revlimid held the highest share in 2018 and is expected to grow at a significant rate during the forecast period. This can be attributed to growing use of this product in cancer treatment regimens.
Rituxan/MabThera held the second largest share in 2018 owing to increasing use of this product in multiple indications and high prescription rate in major markets such as the U.S., Europe, and Japan.
North America dominated in 2018, followed by Europe. This can be attributed to well-established healthcare infrastructure, high R&D expenditure, availability of novel drugs, and presence of key players.
Asia Pacific is expected to be the fastest growing over the forecast period owing to increase in commercialization of products, rise in awareness about diseases and high unmet clinical needs.
Some of the major players are Celgene Corporation; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Seattle Genetics, Inc.; Merck & Co., Inc.; Johnson & Johnson; Takeda Pharmaceutical Company Ltd.; Abbott Laboratories; and Eli Lilly and Company.
Key players for lymphoma treatment market are adopting strategies such as collaborations, mergers & acquisitions, product development, product line extension, and regional expansion to increase their share. For instance, Seattle Genetics collaborated with Takeda Pharmaceuticals for commercialization of Adcetris in different regions other than North America.

Preimplantation Genetic Testing Market Worth $107.3 Million By 2024

The global preimplantation genetic testing market is expected to reach USD 107.3 million by 2024, at a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. It is primarily driven by a rising awareness among couples to undergo diagnostic and screening tests to minimize genetic diseases and aneuploidy in fetus. The ability of preimplantation genetic testing to detect genetic disorders and rare diseases, such as fibrodysplasia ossificans progressive, is anticipated to propel the growth.

High adoption of In Vitro Fertilization (IVF) technique consequently upsurges the utilization of Preimplantation Genetic Diagnosis (PGD). These techniques are advantageous in a way that they allow the development of a healthy fetus and prevent the risk of selective pregnancy termination. Hence, PGT acts as an addendum to assisted reproductive technology.

A substantial number of patients with infertility and impaired fecundity are recommended to embrace IVF therapy in combination with PGT procedures, which in turn is expected to stimulate the growth. In addition, public and private authorities are promoting reproductive health by undertaking initiatives is also anticipated to drive the Preimplantation Genetic Testing (PGT) (PGS/PGD) market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/preimplantation-genetic-testing-pgt-market

Further key findings from the report suggest:

Availability of a significant number of services related to early diagnosis of specific gene mutation in embryo marked the dominant position of PGD in 2018
Preimplantation Genetic Screening (PGS) seems to be reasonable intervention to enhance efficiency of selecting chromosomally normal embryo during IVF cycles. It is increasingly being applied for embryo screening due to ever-expanding IVF, which is projected to create lucrative growth opportunities in near future
Advancements in detection of chromosomal anomalies by executing non-invasive prenatal testing results in a maximum share of this segment in 2018
Expanding utilization rate of FISH probe sets and benefits associated with the detection of a single-gene disorder is expected to fuel the growth of X-linked diseases segment
Implementation of PGT in embryo HLA typing for stem cell therapy is expected to impose segment growth. This is further attributed to the advantages pertaining to PGS testing for identification of HLA compatible embryos during stem cell therapy
Europe accounts for largest revenue share in 2018 owing to increased usage of PGD and PGS for the delivery of genetically healthy offspring during IVF procedures
Asia Pacific market is observed to reveal the fastest CAGR due to the rise in medical tourism and the continuous development of IVF and PGD clinics in Asian countries
Key players that have commercialized PGT services include Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others
Key participants are actively involved in expansion of the distribution network for their products as well as R&D activities for the development of novel PGT services. In October 2018, Illumina Inc. signed an agreement with Vitrolife AB under which Vitrolife act as a distributor supplier of Illumina’s PGT products in EMEA and America.

Europe MRO Distribution Market Size Worth $222.11 Billion By 2028

The Europe MRO distribution market size is expected to reach USD 222.11 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 1.6% from 2021 to 2028. The rise in scheduled maintenance and increasing investments in repair operations are expected to ascend the market growth over the forecast period.

Prominent European industries have adopted integrated repair, maintenance, and operation service concepts for improvements in the equipment and services in critical operations. Many industrial units adopted this change post-recession period and are likely to continue in the projected time. Therefore, the demand for Maintenance, Repair, & Overhaul (MRO) distribution is expected to remain high.

The untapped markets are benefitted owing to the emergence of e-commerce platforms in the European region, thus the penetration of MRO products in the region has escalated. Moreover, the established players in the region have adopted the strategy of acquiring small-scale players to enhance the market presence.

Major players in the regional market are employing several strategies focusing on digital marketing, pricing, product placement, and communication to improve supply channels and enhance sales operations. These enhanced sales processes and standardized sales tools are anticipated to upscale the MRO industry growth in the upcoming future.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/europe-maintenance-repair-overhaul-mro-distribution-market

Further key findings from the study suggest:

The machine consumables product segment accounted for the largest share of 30.2% in 2020 on account of the increasing focus of the end-users on the maintenance and upkeep of critical equipment in order to maintain and enhance their performance and operational lifetime
The external MRO service type segment is anticipated to witness the fastest growth from 2021 to 2028 owing to the increasing contracts to third-party MRO service providers by the product manufacturers to increase the geographical operation
The preventive/scheduled maintenance type segment accounted for the largest share of 58.8% in 2020 and is projected to witness significant growth over the forecast period owing to its rising adoption in order to reduce the breakdown and maintenance time
The machinery and equipment application segment is projected to expand at the fastest CAGR from 2021 to 2028 on account of the growing demand from a diverse range of industry verticals, including construction, automotive, and metalworking
Germany accounted for the largest share of 21.8% in 2020 owing to the high adoption of preventive and scheduled MRO among the manufacturers operating in the country

Europe Passive Fire Protection Market Size Worth $1.3 Billion By 2027

The Europe passive fire protection market size is expected to reach USD 1.3 billion by 2027 registering a CAGR of 3.4%, according to a new report by Grand View Research, Inc. Favorable government regulations about structural fire safety and increasing awareness regarding the same are expected to drive market growth. Growing demand for fire-safe buildings has led to increased investments in terms of installation of passive fire protection systems in the construction sector, which will also boost the market growth.

Increasing investments in exploration and production activities by the oil & gas companies have boosted the demand for hydrocarbon in tumescent coatings. Fire protection is an important aspect of the structural steel safety in industries including oil & gas and chemicals as the risks of fire accidents are high owing to the combustion of hydrocarbon fuels.

Growing demand for high-quality passive fire protection products with improved efficiency and reliability along with the popularity of technologies used in their production is pushing manufacturers to continuously engage in innovation. This is driving them to take the necessary steps to maintain and enhance the standards of their products.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/europe-passive-fire-protection-market

Further key findings from the report suggest:

The cementitious material segment accounted for the largest revenue share of over 41% of the global market owing to the wide usage of steel structures in infrastructure development projects
Construction is expected to be the largest as well as fastest-growing end-use segment over the forecast period owing to the rise in building & construction activities post relaxation of containment measures taken due to the Covid-19 pandemic
The industrial end-use segment accounted for the second-largest market share of over 22% in 2019 owing to the rising emphasis on the improvement of fire safety standards across the regional industries
Germany accounted for the largest market share in 2019 owing to high demand for passive fire safety products from the industrial, automotive, and construction sectors
The market is highly competitive and is characterized by the presence of both global and regional players

North America Building Thermal Insulation Market Worth $13.83 Billion By 2027

The North America building thermal insulation market size is expected to reach USD 13.83 billion by 2027, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 2.7% in terms of revenue during the forecast period. Rising consumer awareness, demand for thermal insulation materials, and favorable regulations owing to the focus on lowering the overall energy consumption are the factors expected to drive market growth.

The market players focus on increasing its market share through organic growth. The companies indulge in the expansion of their product portfolio by developing cost-effective insulation products with enhanced properties and expanding their manufacturing capabilities to cater to the ascending product demand worldwide.

Numerous local and international players in the market provide raw materials for thermal insulating components. Extensive production facilities and high capital investments result in high volume production of materials by prominent players, which is then used to manufacture insulating components.

The industry exhibits a large number of established players controlling significant market share. These companies develop a robust business model to adapt to market volatility and any technological and geographical change. The players usually maintain a strategic relationship with their suppliers to maintain uninterrupted supply.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/north-america-building-thermal-insulation-market

Further Key Findings from the Report Suggest:

Expanded Polystyrene (EPS) is expected to witness the fastest CAGR of 3.1%, from 2020 to 2027, on account of high product penetration owing to the sound absorption, lightweight, and quakeproof nature of the product
The walls application segment dominated the market in 2019 and is expected to reach USD 5.58 billion by 2027, owing to the adoption of high-class architecture and maintaining high energy efficient standards by the residential and commercial structures
Residential end-use application accounted for 5.88 billion in 2019, on account of growth in the number of single-family houses in developing economies and rising disposable income of the consumers
The U.S. dominated the market in 2019 and is expected to reach USD 10.83 billion by 2027, owing to growth in the construction sector and increased demand for energy-efficient construction solutions
The major manufacturers emphasize innovation through extensive R&D for the production of advanced insulating materials. Numerous local players are engaged in manufacturing standard components, which results in stiff competition in the market